OVERVIEW

Oral Tablet Immunotherapy for Allergic Rhinitis: Advancing Management in the Pediatric Setting is organized by Integrity Continuing Education Inc., Global Education Group.

Release date: February 28, 2024
Expiration date: February 28, 2025

Program Overview:
Allergic rhinitis usually presents in early childhood and is caused by an immunoglobulin E (IgE)-mediated reaction to various indoor and outdoor allergens. In this video activity, Dr. Michael Blaiss will discuss the burden of symptoms of allergic rhinitis/rhinoconjunctivitis (AR/C), how to implement strategies for early diagnosis, and the role of allergy immunotherapy in the management of patients with AR/C.

Learning Objectives:
Upon completion of this educational activity, participants should be able to:

  • Discuss the burden of symptoms of AR/C and the associated impacts on quality of life in children and adolescents
  • Discuss how to implement strategies for the early diagnosis and optimal assessment of AR/C in the pediatric setting
  • Describe the role of allergy immunotherapy in the management of patients with AR/C
  • Discuss how to utilize available therapies to achieve optimal management of pediatric patients with AR/C
Credits

Accreditation
Physician Continuing Education
Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
Integrity CE, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Integrity CE, LLC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.25 contact hours (which includes 0.1 hour(s) of pharmacology).

  • 1.25 AMA PRA Category 1 Credits™
  • 1.25 Contact Hours
  • 0.1 Hours
  • TARGET AUDIENCE

    PhysicianNursingPhysician AssistantCliniciansPediatriciansAllergy & immunologyPediatricsFamily Practice physiciansNurse Practitioners

    SPECIALITIES

    PediatricsImmunotherapiesAllergy and Immunology

    RELATED ONLINE COURSES

    3 Hours
    ...
    More actions

    Webcast

    Emergency Medicine
    30 AMA PRA Category 1 Credits™
    ...
    More actions
    US$169

    Webcast

    Emergency Medicine
    More actions
    US$200